)
Stacie Calad-Thomson
North America BD Lead, Healthcare and Life Sciences,
NVIDIA
United States
Stacie, a former pharma and biotech leader, joined NVIDIA in 2024 to further enable AI adoption across healthcare and the life sciences. In her 13+ years at GSK, she led R&D initiatives and co-founded/led the ATOM consortium. More recently, she held leadership roles at AI drug discovery startups Atomwise, where she was a VP of Partnerships, and BioSymetrics, where she was the Chief Strategy Officer. She also served as the Vice Chair of the Alliance for Artificial Intelligence in Healthcare (AAIH) from 2023-2025. Stacie holds a B.S. in Chemistry from UC Berkeley and a Ph.D. in Organic Chemistry from UC Irvine.
Sessions
-
17-Jun-2025Computational Drug Design: Benchmarking Bold Bets, Breakthroughs, and Bottlenecks
-
17-Jun-2025What are the Opportunities and Challenges for the New Generation of TechBio Partnerships Powered by Generative and Foundational AI?
-
22-Jun-2026How Can Generative Genomics Help Us Design Biology Better, Not Just Faster?
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}